The Booming Rise of CANOPY GROWTH CORP (OTCMKTS:TWMJF)

0

CANOPY GROWTH CORP COM NPV(OTCMKTS:TWMJF) has established itself as the leader in MJ penny stocks making spectacular gains in recent months surpassing $35 per share. TWMJF is one exciting story developing in small caps and the largest Marijuana producer in Canada with global ambitions that has been seeing huge growth over the past year. TWMJF has alos become a volume leader on the exchange regularly surpassing $100 million in daily dollar volume.

TWMJF is a powerhosue in the booming  Marijuana industry that has quickly turned into a multi-billion dollar massive growth market that is sweeping across North America. MJ penny stocks are once again booming as they seem to be this time of year with Canadian cannabis stocks gained an estimated 250% as a group in 2017. Recreational marijuana is now legalized in eight states and DC, including California where sales began on January 1. The total U.S. legal marijuana sales are estimated between to be around $7 billion in 2017. While it depends on other states legalizing marijuana, future growth is expected to be strong.

CANOPY GROWTH CORP COM NPV(OTCMKTS:TWMJF) is Canada’s first publicly traded medical marijuana company and the first geographically diversified producer with multiple licenses under the Marijuana for Medical Purposes Regulations. Canopy Growth has established partnerships with leading sector names including cannabis icon Snoop Dogg, breeding legends DNA Genetics and Green House seeds, and Fortune 500 alcohol leader Constellation Brands, to name but a few. Canopy Growth operates seven cannabis production sites with over 665,000 square feet of production capacity, including over 500,000 square feet of GMP-certified production space. The Company has operations in seven countries across four continents. The Company is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public’s understanding of cannabis, and through its partly owned subsidiary, Canopy Health Innovations, has devoted millions of dollars toward cutting edge, commercializable research and IP development. Through partly owned subsidiary Canopy Rivers Corporation, the Company is providing resources and investment to new market entrants and building a portfolio of stable investments in the sector.

TWMJF core brands include Tweed, the most recognized marijuana production brand in the world. It has built a large and loyal following by focusing on quality products and meaningful customer relationships. Tweed doesn’t just sell marijuana, it facilitates a conversation about a product we’ve all heard about but haven’t met intimately yet. It is approachable and friendly, yet reliable and trusted. As marijuana laws liberalize around the world, Tweed will expand its leading Canadian position around the globe.

TWMJF other core brand is Bedrocan, the epitome of medical-grade cannabis. Bedrocan BV pioneered medical cannabis in Holland through decades of selection and refinement, leading to standardized, whole bud cannabis strains that patients can rely on. Bedrocan Canada supplies the same standardized strains to the Canadian market through exclusive licensing rights to the American continents, an arrangement it will also enjoy for all future genetic advancements. Due to its consistency over time, Bedrocan’s strains have been used in clinical research in seven European countries. That commitment to research didn’t stay on the east side of the Atlantic – Bedrocan Canada recently launched one of the largest clinical cannabis studies in the world, the EQUAL Study, to evaluate quality of life before and after medical cannabis use.

To Find out the inside Scoop on TWMJF Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

Earlier this year WEED said it has finalized the purchase of a parcel of land adjacent to its current facility in Niagara-on-the-Lake, ON including an operational 458,000 sq. ft. greenhouse. In addition to the newly acquired asset, construction has commenced on an additional 212,000 sq. ft. of state-of-the-art greenhouse to be located on the current Tweed Farms property, to be completed by April 2018.

All told, Tweed Farms will soon be home to over 1,000,000 sq. ft. of greenhouse space under glass, plus post-harvest facilities including a recently renovated 10,000 sq. ft. of updated space for new drying rooms and an upgraded laboratory. Canopy Growth purchased the property for $9 million with a combination of $6 million in cash and equity totalling up to $3 million in Canopy Growth common shares, of which $2 million is contingent on certain milestones, the latest issuance taking place no later than one year following the closing date of the transaction.  The total number of common shares issued on closing amounted to 111,366 and are subject to a four month lock up.

On January 5 TWMJF announced In response to news out of the United States Department of Justice yesterday morning regarding federal cannabis laws in the United States and further to press releases issued Oct 17, 2017 and Aug. 4, 2017, Canopy Growth Corporation (TSX: WEED) (“Canopy Growth” or the “Company”) wishes to reiterate its commitment to only conducting business in jurisdictions where that conduct is federally legal and otherwise in compliance with all applicable laws.

Canopy Growth does not and will not conduct business in any jurisdiction unless it is federally permissible. Conducting activities which are federally illegal, or investing in companies which do, exposes the Company to increased risk of prosecution. Such activities would compromise Canopy Growth’s ability to operate freely, and could jeopardize the Company’s listing eligibility on major securities exchanges now and in the future, and limit access to capital from reputable US-based funds and world-class partners.

“We want to make our position as clear as possible: While Canopy does not support continued cannabis prohibition, it is Management’s view that confusion surrounding federal cannabis laws in the United States presents advantages for Canopy Growth, not risks. We are confident in our position because we have exclusively focused on ethical, responsible and legal cannabis opportunities across the globe and not in the United States,” said Bruce Linton, Chairman & CEO, Canopy Growth. “We want to assure our shareholders that they are not being exposed to undue risk.”

We have a Monster Pick Coming. Subscribe Right Now!

Currently trading at a $3.3 billion market valuation and running up the charts TWMJF has $115 million in cash and cash equivalents on the books, virtually no debt and significant fast growing revenues reporting $15,873,000 in sales for the 3 months ended June 30, 2017 up from $6,984 for the same period last year. Canopy Growth which is dually listed on both US and Canadian exchanges is one exciting story developing in small caps and the largest Marijuana producer in Canada with global ambitions.; the Company operates three state-of-the-art production facilities in Ontario and distributes marijuana across the country and is poised to emerge as the dominant player in the Canadian marijuana market once federal legalization takes effect on July 1st, 2018. TWMJF has established itself as a leader in the red hot Marijuana industry that has quickly turned into a multi-billion dollar massive growth market and is a must own stock for Investors in pot stocks. We will be updating on TWMJF when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with TWMJF.

Sign Up now for our 100% FREE Penny Stock Newsletter

Disclosure: we hold no position in TWMJF either long or short and we have not been compensated for this article.

Share.

Leave A Reply

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.